Ko-Med Nova Sp. z o.o.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Psoriasis1 trial
• Type 2 diabetes1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Completed2 trials

Lead sponsor

• Celltrion Inc.1 trial
• LEO Pharma1 trial

Closed trials

• Completed

  Clinical study to evaluate the efficacy and safety of Pioglitazone co-administration in patients with type II diabetes with insufficient glycemic control with Metformin and Empagliflozin combination therapy

  2023-508924-36-00· Phase 3· Celltrion Inc.· Source

• Completed

  Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight

  NCT04306315· Phase 4· LEO Pharma· Source